ASTM E2045-1999(2014) Standard Practice for Detailed Clinical Observations of Test Animals《对试验用动物进行详细临床观察的标准实践规程》.pdf
《ASTM E2045-1999(2014) Standard Practice for Detailed Clinical Observations of Test Animals《对试验用动物进行详细临床观察的标准实践规程》.pdf》由会员分享,可在线阅读,更多相关《ASTM E2045-1999(2014) Standard Practice for Detailed Clinical Observations of Test Animals《对试验用动物进行详细临床观察的标准实践规程》.pdf(9页珍藏版)》请在麦多课文档分享上搜索。
1、Designation: E2045 99 (Reapproved 2014)Standard Practice forDetailed Clinical Observations of Test Animals1This standard is issued under the fixed designation E2045; the number immediately following the designation indicates the year oforiginal adoption or, in the case of revision, the year of last
2、revision. A number in parentheses indicates the year of last reapproval. Asuperscript epsilon () indicates an editorial change since the last revision or reapproval.1. Scope1.1 This practice describes the terms used in observing andrecording cutaneous, gastrointestinal, respiratory, reproductive,neu
3、romuscular, ocular, and general clinical signs of animalsundergoing toxicological testing. This practice also assists inproperly observing and assessing laboratory animals for signsof disease or adverse effects of compound administration.1.2 This practice includes codes and descriptions for a wideva
4、riety of clinical signs, anatomical locations, and otherdescriptive qualifiers, and a technique for scoring the extent orseverity of clinical signs.1.3 This practice assumes that the reader is knowledgeablein animal toxicology and related pertinent areas and is trainedin making clinical observations
5、.1.4 This standard does not purport to address all of thesafety concerns, if any, associated with its use. It is theresponsibility of the user of this standard to establish appro-priate safety and health practices and determine the applica-bility of regulatory limitations prior to use.2. Referenced
6、Documents2.1 Federal Standards:Title 40, Code of Federal Regulations (CFR), EnvironmentalProtection Agency, Subchapter E, Pesticide Programs,Part 160, Good Laboratory Practice Standards2Title 40, Code of Federal Regulations (CFR), Toxic Sub-stances Control Act, Part 792, Good Laboratory PracticeStan
7、dards2Title 40, Code of Federal Regulations (CFR), EnvironmentalProtection Agency, Part 798, Health Effects TestingGuidelines23. Significance and Use3.1 This practice pertains to all forms of toxicologicaltesting (acute, subchronic, or chronic) performed by any routeof administration (inhalation, or
8、al, dermal, ocular, or other).3.2 The U.S. Environmental Protection Agency, GoodLaboratory Practices for Nonclinical Laboratory Studies, aslisted in 40 CFR, requires that a testing facility maintainspecific standard operating procedures (SOPs) including anSOP covering clinical observations in test a
9、nimals.3.3 This practice serves as a basis for consistency in clinicalobservations. Actual procedures and forms to be used inrecording observations must be described in individual studyprotocols.4. Procedure4.1 Observe the health of an animal at a distance and of itshousing environment to gain a gen
10、eral impression of its health.Also note environmental factors such as temperature, humidity,ventilation, air quality and hygienic conditions.4.2 Observe each animal and note any subtle changes inanimal behavior, physical appearance, posture, gait,vocalization, food and water consumption, and waste p
11、roduc-tion. See Section 5 for details.4.3 Observe control animals first, followed by test groups inorder of increasing level of treatment. Observe positive controlgroup, if any, last.4.4 Note any dead animals and collect necessary tissues anddata before decomposition occurs.4.5 Report animals that s
12、how signs of sickness so thatappropriate diagnosis, treatment, or euthanasia, if appropriate,can be performed.5. General Clinical Signs5.1 Note the overall activity, behavior, and condition of theanimal. Determine the hydration status by examining skinturgor, position of the eyes such as normal or s
13、unken, mucousmembrane color, and capillary refill time. Look for asymmetryor the presence of abnormal swellings, hemorrhage or signs ofpain.1This practice is under the jurisdiction of ASTM Committee E50 on Environ-mental Assessment, Risk Management and Corrective Action and is the directresponsibili
14、ty of E50.47 on Biological Effects and Environmental Fate.Current edition approved Oct. 1, 2014. Published December 2014. Originallyapproved in 1999. Last previous edition approved in 2009 as E2045 99(2009).DOI: 10.1520/E2045-99R14.2Available from U.S. Government Printing Office, Superintendent ofDo
15、cuments, Washington, DC 20402.Copyright ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959. United States15.2 The following are some general conditions along withsuggested codes for record keeping that do not fall into anyspecific organ system. Refer to Annex A1
16、 Annex A3 for adetailed listing of the codes and their descriptions. Othergeneral reference material will also be helpful.3,4,55.2.1 Activity may be described as: decreased (ACD);increased (ACI); hyperexcitable (HX); hyperactive (HYP);lethargic (LE); irritable (IRR); moribund (MB), that is neardeath
17、; prostate (PRO), that is, exhibiting inability or unwill-ingness to maintain upright posture.5.2.2 Body condition may be described as: obese (OBS);thin (THN); decreased rectal temperature (BTD); increasedrectal temperature (BTI); hypothermia that is cold to touch(HPO); hyperthermia that is warm to
18、touch (HPR).5.2.3 Death may be described as: accidental death (AD);euthanized (ETH); found dead (FD).5.2.4 Examine skin for dehydration (DHY). The skin shouldfall back into place immediately after it is pulled out ofposition; if the skin is pulled out of position and tends to sticktogether or slowly
19、 fall back into place, the animal may bedehydrated. Other signs of dehydration include sunken eyeball(SUN), pale or dry mucous membranes (MM), and a capillaryrefill time of 3 s (CR4). Distinguish between dehydration andvarious types of shock.5.2.5 Generalized edema (EDE) may appear as swelling ofthe
20、 limbs, lower abdomen, head or under the mandible. Whenthe apparently fluid-filled tissue is pressed, an indentation maypersist for a short time.5.2.6 Evidence of hemorrhage (HE) may appear on thehaircoat (HEH) or underlying skin or nails (HES), in urine(HEU) or feces (HEF), from the mouth (HEM), no
21、se orepistaxis (EPI), eyes (HEO), ears (HEE), genitalia (HEG), oranus (HEA).5.2.7 Jaundice (JAU) is an overall slight yellow to paleorange tinge to the skin and mucous membranes.5.2.8 Mucous membrane condition (MM) is noted by thecolor and condition of the mucous membranes of the eye, nose,mouth, or
22、 external genitalia.5.2.9 Swelling (SW) is noted by the size, location andprobable cause, such as edema (SWE) from: a solid tissue ortumor (SWT); blood (SWH); air (SWA); or pus (SWB).6. Specific Clinical Signs6.1 Inspect the entire haircoat and underlying skin forintegumentary signs. Some common cli
23、nical signs and theirsuggested codes are as follows:6.1.1 Alopecia, that is, hair loss (ALO), includes hairthinning, patchy/focal hair loss or balding.6.1.2 Haircoat condition (HC) may be described as: oily(HCO); rough (HCR); wet (HCW); soiled (HCS); dry (D);bloody (HEH); or piloerection (HCP), that
24、 is, distinctly raisedfur, excluding the vibrissae, giving a bristled or porcupine-likeappearance.6.1.3 Swelling (SW) is an increase in tissue size or in-creased abnormal shape of the skin or other organs fromabnormal presence of: air, that is, emphysema (SWA); fluid orwater, that is, edema (SWE); s
- 1.请仔细阅读文档,确保文档完整性,对于不预览、不比对内容而直接下载带来的问题本站不予受理。
- 2.下载的文档,不会出现我们的网址水印。
- 3、该文档所得收入(下载+内容+预览)归上传者、原创作者;如果您是本文档原作者,请点此认领!既往收益都归您。
下载文档到电脑,查找使用更方便
5000 积分 0人已下载
下载 | 加入VIP,交流精品资源 |
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- ASTME204519992014STANDARDPRACTICEFORDETAILEDCLINICALOBSERVATIONSOFTESTANIMALS 试验 动物 进行 详细 临床 观察 标准 实践

链接地址:http://www.mydoc123.com/p-530143.html